IPPH (Isopropylhenidate)
€ 21,95 – € 529,00Price range: € 21,95 through € 529,00
IPPH (Isopropylphenidate) is described as a laboratory research material belonging to the phenidate family of piperidine-derived carboxylate esters.
Its proposed chemical structure incorporates an isopropyl ester group in place of the methyl ester found in methylphenidate, providing a basis for comparative chemical characterization and analytical investigation.
Raw Lab Chems identifies this material exclusively for controlled chemical identification, chromatographic characterization, spectroscopic investigation, and research involving structurally related phenidate compounds.
The supplied information describes both pellet and powder presentations without confirming which formulation applies to the actual catalog item. Claims concerning purity, independent testing, batch consistency, and packaging require supporting product-specific documentation.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
IPPH Isopropylphenidate – Phenidate Research Material
Product Overview
IPPH Isopropylphenidate is described in the supplied information as a laboratory research material associated with isopropylphenidate, a synthetic compound belonging to the phenidate family.
The compound is structurally related to methylphenidate and differs through the substitution of an isopropyl ester group for the corresponding methyl ester.
This structural variation provides a basis for analytical comparisons involving carboxylate ester chemistry, chemical identification, and the characterization of related piperidine derivatives.
Raw Lab Chems presents the material exclusively within a Research Use Only framework.
The supplied source describes both crystalline powder and pellet presentations.
However, it does not establish which presentation corresponds to the actual catalog item.
The source also characterizes the material as laboratory grade and refers to independent analytical verification and controlled manufacturing conditions.
These descriptions remain supplier-provided claims until supported by documentation associated with the actual product and batch.
No clinical, therapeutic, diagnostic, dietary, or consumer-oriented application is represented by this description.
Chemical Identity & Classification
IPPH is the common abbreviation for isopropylphenidate.
The compound is described as a phenidate analogue containing a piperidine ring and an isopropyl carboxylate ester.
The supplied source identifies its chemical structure as isopropyl 2-phenyl-2-(piperidin-2-yl)acetate.
This molecular framework provides a basis for comparing IPPH with other phenidate compounds that differ in their ester substituents.
The supplied source provides the following chemical-reference information:
- Common name: Isopropylphenidate
- Abbreviation: IPPH
- Reported chemical name: Isopropyl 2-phenyl-2-(piperidin-2-yl)acetate
- Chemical classification: Phenidate analogue and piperidine-derived carboxylate ester
- Reported molecular formula: C16H23NO2
No CAS Registry Number or molecular weight was supplied.
The reported formula is reproduced from the source and does not independently establish the composition of the actual product.
The source also does not establish whether the preparation contains the freebase or a particular salt form.
This distinction matters because chemical form can affect molecular weight, solubility, and other analytical characteristics.
The supplied information does not identify a specific stereochemical composition or establish whether the material contains a particular stereoisomeric mixture.
Researchers seeking public chemical-reference information may consult PubChem and confirm that any selected database entry corresponds to the intended compound and chemical form.
Chemical & Physical Characteristics
The supplied source describes IPPH in both pellet and crystalline powder formats.
No product-specific inspection record, pellet-dimension specification, crystalline-form characterization, or formulation report was provided.
The actual physical presentation therefore requires confirmation.
The chemical structure includes a phenyl group, a piperidine ring, and an isopropyl ester.
These features distinguish the proposed compound from structurally related phenidate derivatives containing other ester groups.
The source identifies comparative ester stability and chemical characterization as research topics.
However, no product-specific hydrolysis-rate measurements, stability dataset, or experimentally verified physicochemical profile accompanied the description.
The source also does not provide a verified melting point, quantitative solubility profile, density, particle-size distribution, or hygroscopicity measurement.
If the actual product is supplied as pellets, its physical properties may depend on excipients and manufacturing characteristics that were not disclosed.
The source recommends storage in a cool, dry environment protected from light and identifies temperatures below 25°C as general guidance.
No validated stability study, degradation profile, or experimentally established shelf-life specification accompanied this recommendation.
Researchers should distinguish general storage guidance from verified stability data associated with a particular batch.
Purity & Analytical Verification
The supplied description claims purity of at least 98%, with HPLC and NMR cited as methods of verification.
However, no actual batch-specific Certificate of Analysis, chromatogram, NMR spectrum, mass spectrum, or independent laboratory report was provided.
Accordingly, the stated purity threshold is not independently confirmed for the material described here.
The source identifies HPLC, LC-MS, GC-MS, and NMR spectroscopy as analytical techniques relevant to IPPH investigation.
Such methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.
However, naming an analytical technique does not establish that it was performed on the actual product.
The source also describes mass-spectrometric calibration and toxicological screening as possible laboratory contexts.
These descriptions should not be interpreted as evidence that the supplied material meets certified calibration-standard requirements.
Where a pellet formulation is involved, ingredient purity must also be distinguished from finished-unit composition and content uniformity.
Even if ingredient purity were independently established, that finding would not by itself verify the labeled component amount or the composition of individual units.
Any reported purity or identity result should be evaluated against the actual sample, method documentation, reference materials, and relevant analytical limitations.
No certified reference-material status or independently established purity specification is asserted.
Quality Control & Batch Integrity
The supplied source claims that individual batches undergo HPLC and NMR analysis to confirm purity and structural identity.
It also describes manufacturing controls intended to minimize variation and Certificates of Analysis available for institutional record-keeping.
No actual certificate, laboratory accreditation record, manufacturing audit, quality-system documentation, or batch-specific testing report accompanied these statements.
They therefore remain unverified supplier claims.
For reproducible laboratory investigation, useful documentation may include supplier identification, batch number, chemical identifier, receipt date, storage history, and available analytical findings.
If the product is supplied in pellet form, the identity and purity of the named ingredient should be distinguished from the composition and consistency of the finished units.
If the product is supplied as powder, physical characterization and chemical-form documentation may be relevant to the interpretation of analytical findings.
The supplied information does not establish independently verified content uniformity, excipient composition, or quantitative accuracy of any labeled amount.
Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.
The supplied information does not establish certified reference-material status, metrological traceability, or an assigned measurement uncertainty.
Claims of consistent purity, identity, formulation quality, or manufacturing compliance should be supported by actual analytical records rather than inferred from catalog terminology.
Safety, Handling & Laboratory Precautions
Isopropylphenidate is described as a phenidate-related piperidine derivative requiring appropriate institutional risk assessment and controlled laboratory handling.
Research personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.
The compound’s structural relationship to methylphenidate does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual purity, chemical form, and physical presentation have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Neither a pellet nor powder presentation should be interpreted as evidence of pharmaceutical suitability or authorization for personal use.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes airtight, moisture-resistant packaging intended to protect material integrity.
No packaging-validation study, verified container specification, or actual shipment-condition record accompanied this claim.
The source recommends cool, dry storage protected from light and specifies temperatures below 25°C as general guidance.
No validated stability data was provided to establish that this temperature range is necessary or sufficient for a particular shelf life.
The source also describes professional shipping arrangements but does not provide supporting carrier or transportation-compliance documentation.
Laboratory inventory records should preserve the compound name, any available batch identifier, receipt details, and relevant storage observations.
Where chemical form, physical presentation, or formulation ingredients remain uncertain, the inventory record should preserve those uncertainties rather than assign unverified details.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
Intended Research Use & Market Positioning
The supplied scientific context places IPPH within analytical research involving phenidate derivatives, piperidine chemistry, carboxylate ester characterization, and forensic chemical identification.
Its isopropyl ester structure provides a basis for examining distinctions among related phenidate compounds.
The source also references chromatographic separation, mass-spectrometric characterization, and spectroscopic investigation as areas of laboratory research.
These references describe analytical research contexts and do not establish any human-use application.
For comparative chemical-catalog research, Raw Lab Chems also lists 4F-MPH Pellets and 3-FPM Pellets.
These listings identify other named research materials but do not establish equivalent chemical identity, purity, formulation, or analytical characteristics.
The supplied IPPH catalog reference identifies the product page associated with the material discussed here.
These references provide chemical-catalog context rather than evidence of certified reference-material status or interchangeability.
Ordering, Availability & Fulfillment
The supplied source describes multiple research-scale formats and international shipping options.
However, no specific available quantities, confirmed formulation, current inventory record, carrier documentation, or destination-specific authorization was provided.
Consequently, no particular availability, delivery period, customs-clearance arrangement, or transportation-compliance guarantee is asserted.
Phenidate derivatives may be subject to controlled-substance, analog, or other chemical regulations.
Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substance and chemical form involved.
Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.
Research-only labeling does not establish an exemption from controlled-substance regulations.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
IPPH is described as a phenidate analogue and piperidine-derived carboxylate ester whose legal classification may vary by jurisdiction.
Acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analog, or other chemical regulations.
Researchers and institutions remain responsible for determining legal requirements and obtaining any necessary authorizations.
No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.
| Quantity |
1 grams ,2 grams ,5 grams ,10 grams ,50 grams |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.